Vascular Endothelial Growth Factor (VEGF) Expression in Prostate Cancer and Benign Prostatic Hyperplasia
- 1 June 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 157 (6), 2323-2328
- https://doi.org/10.1016/s0022-5347(01)64774-8
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Vascular Permeability Factor (Vascular Endothelial Growth Factor) is Strongly Expressed in the Normal Male Genital Tract and is Present in Substantial Quantities in SemenJournal of Urology, 1995
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Clinical review: 67: Approach to chemoprevention of prostate cancerJournal of Clinical Endocrinology & Metabolism, 1995
- Molecular and cellular basis of cancer invasion and metastasis: Implications for treatmentBritish Journal of Surgery, 1994
- Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inletThe Annals of Thoracic Surgery, 1994
- The Dilemmas of Prostate CancerScientific American, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971